Yield10 Bioscience Inc reports results for the quarter ended in March - Earnings Summary

Yield10 Bioscience

10/05/2023 22:39

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly
adjusted
loss of 76 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 63 cents per share.
    * Revenue fell 59.7% to $60.00 thousand from a year ago;
analysts
expected $73.33 thousand. 
    * Yield10 Bioscience Inc's reported EPS for the quarter was
a loss
of 76 cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Yield10 Bioscience Inc shares had risen by 8.3% this
quarter and
gained 79.1% so far this year.
    * The company reported a quarterly loss of $3.78 million.
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:39 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.63          -0.76          Missed
 Dec. 31 2022      -0.60          -0.67          Missed
 Sep. 30 2022      -0.65          -0.71          Missed
 Jun. 30 2022      -0.69          -0.70          Missed